Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
The AHA voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer television advertisements and encouraged the agency to “rein in skyrocketing drug prices” for patients and the providers who serve them. “We appreciate CMS’…
The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency for a series of FTC hearings on…
AHA letter to Speaker Ryan and Minority Leader Pelosi expressing strong support for House passage of H.R.1318, the Preventing Maternal Deaths Act.
AHA comments on the National Committee on Vital and Health Statistics’ draft recommendations for the predictability roadmap.
AHA comments on the Department of Homeland Security’s proposed rule that could limit legal immigrants’ future immigration status based on their receipt of public benefits.
AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) methodology for the Department of Health and Human Services-operated permanent risk adjustment program for the 2018 benefit year.
AHA encourages Congressional leaders to pass the Pandemic and All-Hazards Preparedness & Advancing Innovation Act (PAHPAI, S. 2852 & H.R. 6378) before Congress adjourns for 2018.
AHA today urged the United States Pharmacopeial Convention to delay by at least 18 months the effective dates for its general chapter <797> pharmaceutical compounding and general chapter <800> hazardous drug handling in health care settings, as well as proposed revisions to general…
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
Download the letter (PDF) below
Re: CMS—3346—P, Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Proposed Rule (Vol. 83, No. 183), Sept. 20, 2018.